Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial
Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adult...
Saved in:
| Published in | European journal of clinical nutrition Vol. 64; no. 6; pp. 636 - 643 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
01.06.2010
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0954-3007 1476-5640 1476-5640 |
| DOI | 10.1038/ejcn.2010.19 |
Cover
Loading…
| Abstract | Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies. Subjects/Methods: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2–30.7 kg/m2) and abdominal visceral fat area (81.2–178.5 cm2) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. Results: In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): −5.8 (−10.0, −1.7) cm2) and 3.3% (−7.4 (−11.6, −3.1) cm2), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (−1.1 (−1.5, −0.7) kg); BMI, 1.5% (−0.4 (−0.5, −0.2) kg/m2); waist, 1.8% (−1.7 (−2.1, −1.4) cm); hip, 1.5% (−1.5 (−1.8, −1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) μg/ml) and 13.6% (0.23 (0.07, 0.38) μg/ml), respectively. Conclusion: The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. |
|---|---|
| AbstractList | Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies. Subjects/Methods: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n = 87) with higher body mass index (BMI) (24.2-30.7 kg/[m.sup.2]) and abdominal visceral fat area (81.2-178.5 [cm.sup.2]) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM;n = 43) or FM without LG2055 (control FM; n = 44), and were asked to consume 200g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. Results: In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): -5.8 (-10.0, -1.7) [cm.sup.2]) and 3.3% (-7.4 (-11.6, -3.1) [cm.sup.2]), respectively. Body weight and other measures also decreased significantly (P< 0.001) as follows: body weight, 1.4% (-1.1 (-1.5, -0.7) kg); BMI, 1.5% (-0.4 (-0.5, -0.2) kg/[m.sup.2]);waist, 1.8% (-1.7 (-2.1, -1.4)cm);hip, 1.5% (-1.5 (-1.8, -1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) [micro]g/ml) and 13.6% (0.23 (0.07, 0.38) [micro]g/ml), respectively. Conclusion: The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. European Journal of Clinical Nutrition (2010) 64, 636-643; doi: 10.1038/ejcn.2010.19; published online 10 March 2010 Keywords: abdominal fat; body weight and measures; computed tomography; probiotics; cultured milk products; adiponectin Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies. Subjects/Methods: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2–30.7 kg/m2) and abdominal visceral fat area (81.2–178.5 cm2) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. Results: In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): −5.8 (−10.0, −1.7) cm2) and 3.3% (−7.4 (−11.6, −3.1) cm2), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (−1.1 (−1.5, −0.7) kg); BMI, 1.5% (−0.4 (−0.5, −0.2) kg/m2); waist, 1.8% (−1.7 (−2.1, −1.4) cm); hip, 1.5% (−1.5 (−1.8, −1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) μg/ml) and 13.6% (0.23 (0.07, 0.38) μg/ml), respectively. Conclusion: The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. Subjects/Methods: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n = 87) with higher body mass index (BMI) (24.2-30.7 kg/[m.sup.2]) and abdominal visceral fat area (81.2-178.5 [cm.sup.2]) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM;n = 43) or FM without LG2055 (control FM; n = 44), and were asked to consume 200g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. European Journal of Clinical Nutrition (2010) 64, 636-643; doi: 10.1038/ejcn.2010.19; published online 10 March 2010 In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies.BACKGROUND/OBJECTIVESIn spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies.We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2-30.7 kg/m(2)) and abdominal visceral fat area (81.2-178.5 cm(2)) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography.SUBJECTS/METHODSWe conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2-30.7 kg/m(2)) and abdominal visceral fat area (81.2-178.5 cm(2)) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography.In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): -5.8 (-10.0, -1.7) cm(2)) and 3.3% (-7.4 (-11.6, -3.1) cm(2)), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (-1.1 (-1.5, -0.7) kg); BMI, 1.5% (-0.4 (-0.5, -0.2) kg/m(2)); waist, 1.8% (-1.7 (-2.1, -1.4) cm); hip, 1.5% (-1.5 (-1.8, -1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) microg/ml) and 13.6% (0.23 (0.07, 0.38) microg/ml), respectively.RESULTSIn the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): -5.8 (-10.0, -1.7) cm(2)) and 3.3% (-7.4 (-11.6, -3.1) cm(2)), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (-1.1 (-1.5, -0.7) kg); BMI, 1.5% (-0.4 (-0.5, -0.2) kg/m(2)); waist, 1.8% (-1.7 (-2.1, -1.4) cm); hip, 1.5% (-1.5 (-1.8, -1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) microg/ml) and 13.6% (0.23 (0.07, 0.38) microg/ml), respectively.The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders.CONCLUSIONThe probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. Background/Objectives:In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies.Subjects/Methods:We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2-30.7kg/m super(2)) and abdominal visceral fat area (81.2-178.5cm super(2)) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. Results:In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): -5.8 (-10.0, -1.7) cm super(2)) and 3.3% (-7.4 (-11.6, -3.1) cm super(2)), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (-1.1 (-1.5, -0.7) kg); BMI, 1.5% (-0.4 (-0.5, -0.2) kg/m super(2)); waist, 1.8% (-1.7 (-2.1, -1.4) cm); hip, 1.5% (-1.5 (-1.8, -1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) kg/ml) and 13.6% (0.23 (0.07, 0.38) kg/ml), respectively. Conclusion:The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies. Subjects/Methods: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects ( n =87) with higher body mass index (BMI) (24.2–30.7 kg/m 2 ) and abdominal visceral fat area (81.2–178.5 cm 2 ) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n =43) or FM without LG2055 (control FM; n =44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. Results: In the active FM group, abdominal visceral and subcutaneous fat areas significantly ( P <0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): −5.8 (−10.0, −1.7) cm 2 ) and 3.3% (−7.4 (−11.6, −3.1) cm 2 ), respectively. Body weight and other measures also decreased significantly ( P <0.001) as follows: body weight, 1.4% (−1.1 (−1.5, −0.7) kg); BMI, 1.5% (−0.4 (−0.5, −0.2) kg/m 2 ); waist, 1.8% (−1.7 (−2.1, −1.4) cm); hip, 1.5% (−1.5 (−1.8, −1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly ( P <0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) μg/ml) and 13.6% (0.23 (0.07, 0.38) μg/ml), respectively. Conclusion: The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies. We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2-30.7 kg/m(2)) and abdominal visceral fat area (81.2-178.5 cm(2)) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): -5.8 (-10.0, -1.7) cm(2)) and 3.3% (-7.4 (-11.6, -3.1) cm(2)), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (-1.1 (-1.5, -0.7) kg); BMI, 1.5% (-0.4 (-0.5, -0.2) kg/m(2)); waist, 1.8% (-1.7 (-2.1, -1.4) cm); hip, 1.5% (-1.5 (-1.8, -1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) microg/ml) and 13.6% (0.23 (0.07, 0.38) microg/ml), respectively. The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. BACKGROUND/OBJECTIVES: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies. SUBJECTS/METHODS: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n=87) with higher body mass index (BMI) (24.2-30.7 kg/m(2)) and abdominal visceral fat area (81.2-178.5 cm(2)) were randomly assigned to receive either fermented milk (FM) containing LG2055 (active FM; n=43) or FM without LG2055 (control FM; n=44), and were asked to consume 200 g/day of FM for 12 weeks. Abdominal fat area was determined by computed tomography. RESULTS: In the active FM group, abdominal visceral and subcutaneous fat areas significantly (P<0.01) decreased from baseline by an average of 4.6% (mean (confidence interval): -5.8 (-10.0, -1.7) cm(2)) and 3.3% (-7.4 (-11.6, -3.1) cm(2)), respectively. Body weight and other measures also decreased significantly (P<0.001) as follows: body weight, 1.4% (-1.1 (-1.5, -0.7) kg); BMI, 1.5% (-0.4 (-0.5, -0.2) kg/m(2)); waist, 1.8% (-1.7 (-2.1, -1.4) cm); hip, 1.5% (-1.5 (-1.8, -1.1) cm). In the control group, by contrast, none of these parameters decreased significantly. High-molecular weight adiponectin in serum increased significantly (P<0.01) in the active and control groups by 12.7% (0.17 (0.07, 0.26) microg/ml) and 13.6% (0.23 (0.07, 0.38) microg/ml), respectively. CONCLUSION: The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders. [PUBLICATION ABSTRACT] |
| Audience | Professional Academic |
| Author | Sato, M Imaizumi, K Akai, Y Ikuyama, K Tsuchida, T Kadooka, Y Ogawa, A Kagoshima, M Okano, M |
| Author_xml | – sequence: 1 fullname: Kadooka, Y – sequence: 2 fullname: Sato, M – sequence: 3 fullname: Imaizumi, K – sequence: 4 fullname: Ogawa, A – sequence: 5 fullname: Ikuyama, K – sequence: 6 fullname: Akai, Y – sequence: 7 fullname: Okano, M – sequence: 8 fullname: Kagoshima, M – sequence: 9 fullname: Tsuchida, T |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22807363$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20216555$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkltrFTEQxxep2Iu--axBERU8NffsPtbiDQqCbZ9DNjt7TMlJTpMsUj-FH9lse0qxtJQM5DK_uWT47zZbIQZomucE7xPM2o9wZsM-xfO1e9TsEK7kQkiOt5od3Am-YBir7WY35zOMq1PRJ802xZRIIcRO8_cnLCdviosBxRGZfogrF4xHZnDrmF25QP0FWqfYu1iczejdkbEl9sY676eMliZnSA4dfzqhWIj3yIUaOvmS0W9XfqHYQwZUIAwQrIN86UfJhLnOHxiQjaGk6H09luSMf9o8Ho3P8Gyz7zWnXz6fHH5bHP34-v3w4GhhJZZl0fGWGAGdNaoaA8U6wnEnh7YXGDosJOUCCKlQz3hnRtUyayUYSu3A6cj2mrdXeevfzifIRa9ctuC9CRCnrJVQquVciYdJLnHLKJMPk4wRKoRUlXx1izyLU6pzz5oJ2fJaeoZe3wdRyauRlogbamk8aBfGWJKxc2F9QGlLFJWXBRd3UEsIkIyvghpdff6P37-Dr2uAlbN3BrzYNDv1Kxj0OrmVSRf6WmoVeLMBTLbGj1UD1uUbjrZY1RlWjl5xNsWcE4zaunIp0NqB85pgPetez7rXs-416WrQh1tB13nvwTfTyBULS0g3k72Hf3nFjyZqs0y179Pj6mSYtEJgItk_dgMYlg |
| CitedBy_id | crossref_primary_10_2106_JBJS_OA_23_00153 crossref_primary_10_3390_ijms21082890 crossref_primary_10_29219_fnr_v65_8087 crossref_primary_10_3389_fmicb_2018_00710 crossref_primary_10_1007_s12257_020_0309_x crossref_primary_10_1016_j_nut_2013_12_004 crossref_primary_10_1371_journal_pone_0123854 crossref_primary_10_2217_fmb_15_13 crossref_primary_10_3390_foods10061261 crossref_primary_10_1080_08905436_2018_1443822 crossref_primary_10_3390_metabo12040278 crossref_primary_10_3390_medicina54050077 crossref_primary_10_1007_s00210_021_02177_0 crossref_primary_10_1099_mic_0_054247_0 crossref_primary_10_1080_19490976_2020_1747330 crossref_primary_10_3748_wjg_v27_i1_107 crossref_primary_10_1016_j_micpath_2012_09_013 crossref_primary_10_1017_S0954422421000160 crossref_primary_10_3390_nu13051450 crossref_primary_10_1139_h11_101 crossref_primary_10_1080_09168451_2017_1295799 crossref_primary_10_1016_j_bpg_2014_07_001 crossref_primary_10_3390_ph7090954 crossref_primary_10_1016_j_ebiom_2016_10_036 crossref_primary_10_1161_CIRCULATIONAHA_115_018585 crossref_primary_10_3389_fmicb_2017_01265 crossref_primary_10_1016_j_mam_2012_11_001 crossref_primary_10_1186_s13099_024_00664_2 crossref_primary_10_3390_nu10050643 crossref_primary_10_15407_fz60_02_063 crossref_primary_10_1016_j_atherosclerosis_2018_02_036 crossref_primary_10_1186_s12944_015_0019_0 crossref_primary_10_1016_j_ddmod_2019_08_006 crossref_primary_10_1111_apha_12145 crossref_primary_10_4327_jsnfs_76_343 crossref_primary_10_1371_journal_pone_0177106 crossref_primary_10_1016_j_heliyon_2024_e37609 crossref_primary_10_1139_apnm_2018_0645 crossref_primary_10_2174_0115733998262859231020071715 crossref_primary_10_1017_jns_2015_5 crossref_primary_10_1016_j_bone_2020_115317 crossref_primary_10_1017_S1368980024002003 crossref_primary_10_1016_j_jff_2019_103666 crossref_primary_10_3390_jcm9061788 crossref_primary_10_1016_j_clnesp_2020_12_007 crossref_primary_10_1039_C9FO00926D crossref_primary_10_1111_mmi_13153 crossref_primary_10_1093_femsre_fuac008 crossref_primary_10_15406_aowmc_2019_09_00269 crossref_primary_10_3389_fgene_2016_00224 crossref_primary_10_1016_j_clnu_2020_10_028 crossref_primary_10_7453_gahmj_2014_018 crossref_primary_10_1016_j_pharmthera_2011_01_012 crossref_primary_10_1007_s11892_018_1104_3 crossref_primary_10_1080_01635581_2021_1933096 crossref_primary_10_3168_jds_2020_19256 crossref_primary_10_12938_bmfh_18_001 crossref_primary_10_3389_fmicb_2022_828275 crossref_primary_10_1210_er_2017_00192 crossref_primary_10_3389_fendo_2021_747888 crossref_primary_10_1021_acs_jafc_9b04879 crossref_primary_10_3390_ijms17060928 crossref_primary_10_1016_j_jff_2018_03_039 crossref_primary_10_1089_jmf_2017_3937 crossref_primary_10_1039_C8FO00209F crossref_primary_10_18632_oncotarget_5906 crossref_primary_10_3920_BM2012_0019 crossref_primary_10_1111_jam_15740 crossref_primary_10_1016_j_micpath_2016_01_002 crossref_primary_10_1155_2019_3291367 crossref_primary_10_1146_annurev_psych_010418_102936 crossref_primary_10_1007_s00253_016_7953_2 crossref_primary_10_1016_j_biopha_2022_112678 crossref_primary_10_3168_jds_2015_9916 crossref_primary_10_1017_S0029665114001670 crossref_primary_10_3390_genes9030167 crossref_primary_10_1159_000354896 crossref_primary_10_1016_j_idairyj_2016_09_010 crossref_primary_10_1017_jns_2016_12 crossref_primary_10_1093_jambio_lxae264 crossref_primary_10_1007_s11908_012_0301_5 crossref_primary_10_1007_s00394_022_02839_6 crossref_primary_10_1096_fj_202300864RR crossref_primary_10_12965_jer_2244272_136 crossref_primary_10_3389_fimmu_2015_00076 crossref_primary_10_4155_fmc_14_167 crossref_primary_10_51847_Q7QvXU3iyN crossref_primary_10_1089_jmf_2010_1355 crossref_primary_10_1016_j_tige_2020_03_003 crossref_primary_10_3389_fimmu_2017_00417 crossref_primary_10_1194_jlr_R066514 crossref_primary_10_1089_chi_2015_0220 crossref_primary_10_1371_journal_pone_0154329 crossref_primary_10_1093_advances_nmaa030 crossref_primary_10_3390_antibiotics12040635 crossref_primary_10_1179_1476830513Y_0000000099 crossref_primary_10_1002_cbdv_202100987 crossref_primary_10_3390_ijms17040481 crossref_primary_10_1007_s12602_017_9375_6 crossref_primary_10_3389_fmicb_2024_1436378 crossref_primary_10_3390_molecules21101351 crossref_primary_10_1007_s12088_019_00808_y crossref_primary_10_1007_s13679_019_00332_6 crossref_primary_10_1111_jam_15703 crossref_primary_10_1038_s42003_022_04380_y crossref_primary_10_3390_nu8070397 crossref_primary_10_1016_j_jaci_2014_11_012 crossref_primary_10_3390_nu17010009 crossref_primary_10_17116_profmed201821345 crossref_primary_10_3390_nu16060815 crossref_primary_10_4251_wjgo_v14_i9_1665 crossref_primary_10_3109_09637486_2013_775229 crossref_primary_10_1016_j_micres_2024_127972 crossref_primary_10_1186_s12864_018_5285_6 crossref_primary_10_1038_nrgastro_2010_102 crossref_primary_10_20473_mgk_v10i1_2021_149_156 crossref_primary_10_3109_09637486_2013_775224 crossref_primary_10_1186_s13098_019_0400_7 crossref_primary_10_1017_S0007114511003163 crossref_primary_10_1007_s13167_020_00198_y crossref_primary_10_1002_fft2_515 crossref_primary_10_7570_kjo_2015_24_3_121 crossref_primary_10_7759_cureus_49271 crossref_primary_10_3168_jds_2018_15203 crossref_primary_10_1016_j_foohum_2024_100423 crossref_primary_10_7570_jomes_2019_28_4_216 crossref_primary_10_1016_j_jff_2017_09_029 crossref_primary_10_1016_j_tifs_2023_01_002 crossref_primary_10_1093_cdn_nzab006 crossref_primary_10_1016_j_jaim_2021_09_003 crossref_primary_10_1016_j_jped_2014_08_005 crossref_primary_10_3390_nu15010028 crossref_primary_10_1155_2012_872716 crossref_primary_10_3389_fphys_2015_00341 crossref_primary_10_1007_s00253_011_3753_x crossref_primary_10_1590_s2175_97902017000116059 crossref_primary_10_4327_jsnfs_72_79 crossref_primary_10_1155_2021_6676502 crossref_primary_10_1111_ijfs_12810 crossref_primary_10_3390_cimb45090452 crossref_primary_10_1371_journal_pone_0031113 crossref_primary_10_1007_s12263_015_0472_4 crossref_primary_10_1016_j_arteri_2018_03_004 crossref_primary_10_7570_jomes21088 crossref_primary_10_1007_s11673_020_10047_2 crossref_primary_10_1017_S002966512100077X crossref_primary_10_1111_j_1365_2796_2010_02270_x crossref_primary_10_3402_jom_v4i0_9367 crossref_primary_10_1097_MCO_0b013e32835133cb crossref_primary_10_3390_ijms17040447 crossref_primary_10_1007_s00253_013_5346_3 crossref_primary_10_3390_foods10071580 crossref_primary_10_3390_ijms231810980 crossref_primary_10_1002_oby_20632 crossref_primary_10_1371_journal_pone_0156811 crossref_primary_10_1007_s00394_015_0846_9 crossref_primary_10_3390_microorganisms3020213 crossref_primary_10_36290_csf_2018_010 crossref_primary_10_1517_14728222_2015_1028361 crossref_primary_10_1108_NFS_05_2018_0139 crossref_primary_10_3920_BM2017_0141 crossref_primary_10_5851_kosfa_2014_34_6_836 crossref_primary_10_3390_nu11112690 crossref_primary_10_1039_D0FO01006E crossref_primary_10_1007_s12263_011_0230_1 crossref_primary_10_1038_s41366_019_0336_x crossref_primary_10_1007_s00592_012_0444_8 crossref_primary_10_3164_jcbn_21_96 crossref_primary_10_3390_ijms15034158 crossref_primary_10_1016_j_biopha_2022_112891 crossref_primary_10_3390_nu10111613 crossref_primary_10_3402_fnr_v59_29273 crossref_primary_10_1210_jc_2017_00513 crossref_primary_10_1136_bmjopen_2017_017995 crossref_primary_10_2991_artres_k_200429_001 crossref_primary_10_1371_journal_pone_0105370 crossref_primary_10_1080_09637486_2016_1181156 crossref_primary_10_3839_jabc_2018_003 crossref_primary_10_1002_fsn3_1996 crossref_primary_10_1371_journal_pone_0185964 crossref_primary_10_1016_j_fct_2022_113440 crossref_primary_10_1038_s41598_019_39602_7 crossref_primary_10_3920_BM2020_0111 crossref_primary_10_1097_j_pbj_0000000000000111 crossref_primary_10_2174_1389200224666230410094806 crossref_primary_10_1186_1475_2891_12_138 crossref_primary_10_1007_s00018_015_2061_5 crossref_primary_10_1007_s12602_016_9233_y crossref_primary_10_1007_s00253_018_9554_8 crossref_primary_10_1016_j_fochx_2023_100993 crossref_primary_10_1371_journal_pone_0202910 crossref_primary_10_1093_cdn_nzaa095 crossref_primary_10_1016_j_trsl_2020_07_012 crossref_primary_10_1017_S0007114513001037 crossref_primary_10_1002_mnfr_201801078 crossref_primary_10_1053_j_gastro_2016_12_048 crossref_primary_10_1080_10408398_2012_733894 crossref_primary_10_1038_ijo_2011_153 crossref_primary_10_3945_an_114_005835 crossref_primary_10_3390_applmicrobiol3010002 crossref_primary_10_1016_j_sjbs_2020_10_022 crossref_primary_10_1016_j_bpg_2013_03_017 crossref_primary_10_3390_metabo14020129 crossref_primary_10_1007_s43440_021_00336_x crossref_primary_10_3390_amh70010005 crossref_primary_10_1371_journal_pone_0108827 crossref_primary_10_3390_nu16091373 crossref_primary_10_1017_S0007114520000380 crossref_primary_10_3390_nu11030635 crossref_primary_10_1007_s10298_011_0619_4 crossref_primary_10_3892_etm_2016_3293 crossref_primary_10_1016_j_artere_2018_10_002 crossref_primary_10_34019_1982_8047_2018_v44_13963 crossref_primary_10_1017_S0954422413000152 crossref_primary_10_1016_j_mehy_2012_04_016 crossref_primary_10_1038_nrendo_2011_126 crossref_primary_10_1038_s41398_018_0116_8 crossref_primary_10_1017_S0007114515002627 crossref_primary_10_1017_S0007114513003875 crossref_primary_10_1155_2016_5080438 crossref_primary_10_1002_jcb_27343 crossref_primary_10_1519_JSC_0000000000002675 crossref_primary_10_1017_S0007114511001036 crossref_primary_10_1017_S0007114518001861 crossref_primary_10_3389_fmicb_2019_01312 crossref_primary_10_1007_s00394_016_1317_7 crossref_primary_10_1177_1559827619843833 crossref_primary_10_3389_fimmu_2021_678355 crossref_primary_10_1093_nutrit_nuz001 crossref_primary_10_1038_s41598_019_43092_y crossref_primary_10_22207_JPAM_15_3_53 crossref_primary_10_1007_s00394_018_1790_2 crossref_primary_10_1016_j_jaci_2013_06_025 crossref_primary_10_3389_fphar_2018_00596 crossref_primary_10_1097_MCO_0b013e328348c06d crossref_primary_10_3390_microorganisms12061036 crossref_primary_10_1016_j_molmet_2022_101517 crossref_primary_10_1038_s41430_022_01135_0 crossref_primary_10_1080_16546628_2017_1318034 crossref_primary_10_1111_ijpo_12273 crossref_primary_10_3390_nu15245025 crossref_primary_10_1038_s41366_018_0220_0 crossref_primary_10_1016_S1473_3099_13_70179_8 crossref_primary_10_1016_j_biotechadv_2018_09_003 crossref_primary_10_1016_j_jff_2018_10_039 crossref_primary_10_1089_jmf_2019_4627 crossref_primary_10_3390_microorganisms8020304 crossref_primary_10_3920_BM2020_0148 crossref_primary_10_3920_BM2010_0030 crossref_primary_10_3389_fnut_2022_1063584 crossref_primary_10_1016_j_jbiotec_2012_07_006 crossref_primary_10_3389_fmolb_2022_1038830 crossref_primary_10_3920_BM2015_0069 crossref_primary_10_1007_s00394_013_0568_9 crossref_primary_10_3390_ijerph120100162 crossref_primary_10_1016_j_jff_2013_04_014 crossref_primary_10_1016_j_phrs_2012_10_021 crossref_primary_10_1016_S0895_3988_15_30116_1 crossref_primary_10_1016_j_jff_2015_08_031 crossref_primary_10_1007_s42000_018_0003_y crossref_primary_10_3389_fphar_2020_584090 crossref_primary_10_1016_j_clnu_2023_03_017 crossref_primary_10_1007_s00394_014_0715_y crossref_primary_10_1016_j_bbr_2020_112718 crossref_primary_10_3168_jds_2014_8860 crossref_primary_10_1186_s13059_016_1052_7 crossref_primary_10_4161_gmic_19246 crossref_primary_10_1111_j_1348_0421_2012_00512_x crossref_primary_10_1007_s12020_017_1433_z crossref_primary_10_1515_jbcpp_2018_0150 crossref_primary_10_3389_fnut_2022_992947 crossref_primary_10_4239_wjd_v14_i10_1502 crossref_primary_10_1080_10408398_2020_1733483 crossref_primary_10_1016_j_micpath_2012_05_007 crossref_primary_10_1016_j_obmed_2017_09_003 crossref_primary_10_1096_fj_201801672R crossref_primary_10_3390_nu11010149 crossref_primary_10_1038_s12276_020_00502_w crossref_primary_10_1016_j_lwt_2020_109296 crossref_primary_10_1038_s12276_019_0293_4 crossref_primary_10_1111_lam_12491 crossref_primary_10_3390_microorganisms8121907 crossref_primary_10_1002_oby_21671 crossref_primary_10_1007_s11906_020_01080_y crossref_primary_10_25279_sak_1180551 crossref_primary_10_3390_nu16081137 crossref_primary_10_1016_j_tifs_2017_01_001 crossref_primary_10_1007_s10482_020_01474_7 crossref_primary_10_3136_fstr_25_435 crossref_primary_10_1146_annurev_nutr_072610_145146 crossref_primary_10_3390_nu12123703 crossref_primary_10_3390_foods13071124 crossref_primary_10_1039_C5FO00367A crossref_primary_10_3390_nu9091021 crossref_primary_10_1038_ijo_2013_20 crossref_primary_10_1016_j_foodcont_2016_04_037 crossref_primary_10_3390_cimb46100682 crossref_primary_10_1089_chi_2017_0122 crossref_primary_10_3390_nu16152436 crossref_primary_10_1016_j_febslet_2014_03_035 crossref_primary_10_1016_j_tifs_2013_08_007 crossref_primary_10_1097_MPG_0b013e3182533a2b crossref_primary_10_1016_j_tifs_2021_04_040 crossref_primary_10_52831_kjhs_1100508 crossref_primary_10_1007_s12519_022_00664_9 crossref_primary_10_1021_acs_jafc_1c04291 crossref_primary_10_3390_foods10020299 crossref_primary_10_1155_2022_2967977 crossref_primary_10_1016_j_phrs_2022_106614 crossref_primary_10_1016_j_fbio_2025_105848 crossref_primary_10_1016_j_bbrc_2018_05_105 crossref_primary_10_1186_1878_5085_5_2 crossref_primary_10_4158_EP151157_RA crossref_primary_10_1007_s11892_018_1020_6 crossref_primary_10_1016_j_jff_2018_07_012 crossref_primary_10_1017_jns_2012_29 crossref_primary_10_1093_nutrit_nuu006 crossref_primary_10_1080_09637486_2021_1886255 crossref_primary_10_3920_BM2018_0028 crossref_primary_10_3109_07853890_2015_1071872 crossref_primary_10_1038_s41598_020_78285_3 crossref_primary_10_4103_jpbs_JPBS_47_19 crossref_primary_10_1016_j_molmet_2019_01_012 crossref_primary_10_1007_s00394_019_02117_y crossref_primary_10_1093_ilar_ilv006 crossref_primary_10_1016_j_fbio_2021_101115 crossref_primary_10_4236_abb_2016_711045 crossref_primary_10_2174_1570161117666181129095941 crossref_primary_10_3389_fendo_2022_1011994 crossref_primary_10_1016_j_tifs_2011_05_006 crossref_primary_10_1016_j_nut_2018_03_005 crossref_primary_10_1128_cmr_00045_23 crossref_primary_10_3390_nu15204458 crossref_primary_10_1016_j_nut_2012_07_017 crossref_primary_10_1186_1476_511X_13_36 crossref_primary_10_1177_0300060519896714 crossref_primary_10_7717_peerj_6651 crossref_primary_10_1016_j_clnu_2021_06_023 crossref_primary_10_1111_obr_13667 crossref_primary_10_3389_fnut_2021_693412 crossref_primary_10_3390_ijms21155242 crossref_primary_10_1016_j_clinthera_2020_12_021 crossref_primary_10_1016_j_pnpbp_2014_08_018 crossref_primary_10_1016_j_alit_2017_07_010 crossref_primary_10_1111_jfbc_12336 crossref_primary_10_48022_mbl_2202_02001 crossref_primary_10_1007_s12328_010_0154_0 crossref_primary_10_1007_s00284_020_02090_4 crossref_primary_10_3390_nu6031016 crossref_primary_10_1177_0884533615620350 crossref_primary_10_1007_s13594_016_0288_z crossref_primary_10_1002_oby_21230 crossref_primary_10_3390_microorganisms8081148 crossref_primary_10_23736_S2724_5276_22_06964_6 crossref_primary_10_1016_j_foodres_2020_109269 crossref_primary_10_1590_0004_2730000002940 crossref_primary_10_1186_s12986_023_00739_y crossref_primary_10_1016_j_micres_2020_126597 crossref_primary_10_1177_2158244018772888 crossref_primary_10_1038_s41598_020_60991_7 crossref_primary_10_1186_s12866_015_0515_4 crossref_primary_10_1016_j_jpedp_2014_08_006 crossref_primary_10_3390_nu13103627 crossref_primary_10_3390_nu15030661 crossref_primary_10_3920_BM2014_0012 crossref_primary_10_3920_BM2014_0014 crossref_primary_10_1007_s00253_020_10634_8 crossref_primary_10_1007_s00253_020_10449_7 crossref_primary_10_1093_nutrit_nuv015 crossref_primary_10_3390_nu16071039 crossref_primary_10_1186_1475_2859_10_S1_S10 crossref_primary_10_6061_clinics_2020_e1277 crossref_primary_10_1038_ijo_2017_161 crossref_primary_10_3389_fmicb_2023_1264356 crossref_primary_10_23736_S2724_5985_21_02909_0 crossref_primary_10_3389_fnut_2022_922993 crossref_primary_10_1017_S0007114516002245 crossref_primary_10_1186_s12986_016_0067_0 crossref_primary_10_1155_2014_651895 crossref_primary_10_4082_kjfm_2013_34_2_80 crossref_primary_10_6064_2012_424780 crossref_primary_10_1016_j_fbio_2024_104786 crossref_primary_10_12938_bmfh_32_51 crossref_primary_10_3920_BM2012_0069 crossref_primary_10_1002_jsfa_6095 crossref_primary_10_1016_j_envres_2023_115921 crossref_primary_10_29105_respyn17_1_5 crossref_primary_10_1002_ddr_21091 crossref_primary_10_1002_ddr_21092 crossref_primary_10_1111_jam_13137 crossref_primary_10_1155_2013_986734 crossref_primary_10_29219_fnr_v64_3751 crossref_primary_10_3748_wjg_v27_i41_7041 crossref_primary_10_1007_s00394_013_0519_5 crossref_primary_10_1016_j_psj_2021_101612 crossref_primary_10_1007_s00213_021_05866_z crossref_primary_10_1007_s00253_016_7414_y crossref_primary_10_1007_s12223_023_01124_1 crossref_primary_10_1002_jcla_24420 crossref_primary_10_3390_nu11020258 crossref_primary_10_3390_nu13020666 crossref_primary_10_1093_jn_nxab103 crossref_primary_10_1016_j_nut_2017_06_024 crossref_primary_10_1016_j_jff_2016_04_014 crossref_primary_10_3390_foods10123099 crossref_primary_10_1016_j_jksus_2020_01_011 crossref_primary_10_1155_2011_989657 crossref_primary_10_1016_j_pranut_2015_06_007 crossref_primary_10_1080_19490976_2018_1465157 crossref_primary_10_3390_foods11162438 crossref_primary_10_3390_ijms25052671 crossref_primary_10_17116_klinderma201514211_16 crossref_primary_10_1186_s13167_015_0036_0 crossref_primary_10_1161_CIRCRESAHA_117_309008 crossref_primary_10_1016_j_bbih_2024_100923 crossref_primary_10_3390_ijms252212066 crossref_primary_10_1016_j_jff_2015_02_013 crossref_primary_10_1186_s13098_024_01561_z crossref_primary_10_3945_ajcn_115_120170 crossref_primary_10_1016_j_clnu_2019_03_034 crossref_primary_10_3390_ijms25010438 crossref_primary_10_1111_bph_12327 crossref_primary_10_1128_AEM_03001_16 crossref_primary_10_1016_j_jff_2015_10_006 crossref_primary_10_1038_srep27780 crossref_primary_10_1097_SPC_0000000000000265 crossref_primary_10_1016_j_ctim_2019_01_018 crossref_primary_10_1080_09168451_2018_1451738 crossref_primary_10_1186_s13578_017_0183_1 crossref_primary_10_1371_journal_pone_0126931 crossref_primary_10_1016_j_clnu_2025_02_007 crossref_primary_10_3389_fnut_2022_976020 crossref_primary_10_1007_s00281_013_0399_z crossref_primary_10_1039_C9FO00293F crossref_primary_10_23736_S0026_4806_22_07992_7 crossref_primary_10_1177_0148607115601985 crossref_primary_10_1016_j_envres_2015_06_026 crossref_primary_10_3390_microorganisms8111715 crossref_primary_10_1111_obr_12626 crossref_primary_10_36316_gcatr_01_0020 crossref_primary_10_1016_j_jff_2017_06_029 crossref_primary_10_1038_ctg_2015_16 crossref_primary_10_1097_MOL_0b013e32835b4431 crossref_primary_10_1016_j_ajcnut_2023_05_003 crossref_primary_10_1007_s00394_018_1873_0 crossref_primary_10_1007_s00253_016_7863_3 crossref_primary_10_1016_j_bbrc_2012_12_121 crossref_primary_10_1128_spectrum_01196_24 crossref_primary_10_3748_wjg_v20_i43_16079 crossref_primary_10_3945_jn_115_227504 crossref_primary_10_1038_s41598_024_72961_4 crossref_primary_10_1002_btpr_2937 crossref_primary_10_1016_j_idairyj_2018_11_002 crossref_primary_10_1093_cid_civ177 crossref_primary_10_1007_s13679_012_0038_3 crossref_primary_10_1155_2021_1583154 crossref_primary_10_1177_1756283X13482996 crossref_primary_10_1002_bies_201400071 crossref_primary_10_1017_S0007114516004037 crossref_primary_10_1016_j_idairyj_2011_02_001 crossref_primary_10_1371_journal_pone_0185098 crossref_primary_10_4014_jmb_2107_07024 crossref_primary_10_1016_j_clnu_2018_09_033 crossref_primary_10_3389_fcvm_2020_00022 crossref_primary_10_3390_gastroent13010006 crossref_primary_10_1007_s12275_020_0266_2 crossref_primary_10_15171_mejdd_2017_66 crossref_primary_10_1097_TIN_0000000000000134 crossref_primary_10_1021_acs_jafc_7b03764 crossref_primary_10_1080_15502783_2024_2425609 crossref_primary_10_1016_j_jnutbio_2019_108256 crossref_primary_10_3390_microorganisms11071862 crossref_primary_10_1007_s12170_013_0293_1 crossref_primary_10_1002_2211_5463_12024 |
| Cites_doi | 10.4065/83.4.460 10.1016/0163-7827(94)00006-8 10.4109/jslab1997.13.114 10.1080/07315724.2005.10719502 10.1017/S0007114507839006 10.12938/bifidus1996.21.179 10.1038/sj.ijo.0802314 10.1111/j.1348-0421.2006.tb03862.x 10.1161/01.ATV.0000099786.99623.EF 10.1161/CIRCULATIONAHA.106.675355 10.1079/BJN20051428 10.1161/01.RES.0000119921.86460.37 10.1038/nature05414 10.1074/jbc.M300365200 10.1074/jbc.M510258200 10.1046/j.1365-2672.2001.01251.x 10.2337/db06-1491 10.1271/bbb.64.2201 10.1111/j.1365-2826.2006.01456.x 10.1017/S0007114508043808 10.1155/2008/829101 10.1271/bbb.61.179 10.1097/MED.0b013e328308dbfb 10.1016/j.femsle.2005.07.006 10.2337/diacare.19.6.629 10.1196/annals.1367.008 10.1210/jc.2006-1158 10.1002/j.1550-8528.1994.tb00076.x 10.1210/jcem-68-1-191 10.3168/jds.S0022-0302(99)75229-X 10.1038/sj.ejcn.1601869 10.1128/AEM.02950-05 10.1093/jn/135.12.2749 10.2337/diabetes.52.1.172 10.2337/dc05-1801 10.1038/4441022a |
| ContentType | Journal Article |
| Copyright | Macmillan Publishers Limited 2010 2015 INIST-CNRS COPYRIGHT 2010 Nature Publishing Group Macmillan Publishers Limited 2010. Copyright Nature Publishing Group Jun 2010 |
| Copyright_xml | – notice: Macmillan Publishers Limited 2010 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2010 Nature Publishing Group – notice: Macmillan Publishers Limited 2010. – notice: Copyright Nature Publishing Group Jun 2010 |
| DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QP 7RV 7TK 7X2 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9. KB0 LK8 M0K M0S M1P M2O M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7QL 7QO 7T7 8FD C1K FR3 P64 7S9 L.6 |
| DOI | 10.1038/ejcn.2010.19 |
| DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Agriculture Science Database ProQuest Health & Medical Collection Medical Database Research Library Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Agricultural & Environmental Science Collection ProQuest Research Library ProQuest Public Health ProQuest Central Basic British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic Biotechnology Research Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic Biotechnology Research Abstracts MEDLINE Agricultural Science Database Agricultural Science Database AGRICOLA |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Diet & Clinical Nutrition Medicine Public Health |
| EISSN | 1476-5640 |
| EndPage | 643 |
| ExternalDocumentID | 2047099341 A228172667 20216555 22807363 10_1038_ejcn_2010_19 US201301855016 |
| Genre | Randomized Controlled Trial Multicenter Study Journal Article |
| GroupedDBID | --- -ET -Q- .GJ 0R~ 29G 2WC 36B 39C 3V. 4.4 406 53G 5GY 5RE 6PF 70F 7RV 7X2 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 A8Z AADWK AAIKC AAMNW AANZL AATNV AAWBL AAWTL AAYFA AAYJO AAZLF ABAWZ ABCQX ABDBF ABGIJ ABJNI ABLJU ABOCM ABPTK ABUWG ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACKTT ACMJI ACPRK ACRQY ACTTH ACVWB ADBBV ADFRT ADHDB ADHUB ADMDM ADQMX ADYYL AEDAW AEFTE AEJRE AENEX AEVLU AEXYK AFKRA AFNRJ AFRAH AFSHS AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AI. AILAN AJCLW AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AN0 APEBS ATCPS AXYYD AZQEC B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BKOMP BNQBC BPHCQ BVXVI CCPQU CS3 DIK DNIVK DPUIP DU5 DWQXO E.L E3Z EAD EAP EAS EBC EBD EBLON EBO EBS ECGQY EE. EHN EIOEI EJD EMB EMK EMOBN EPL EPT ESTFP ESX EX3 F5P FBQ FDQFY FERAY FIZPM FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HZ~ IAG IAO ICU IEA IHR IHT IHW INH INR IOF ITC IWAJR JSO JZLTJ KQ8 LGEZI LOTEE M0K M1P M2O M7P NADUK NAO NAPCQ NQJWS NXXTH NYICJ O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X Q~Q RNS RNT RNTTT RXW SNX SNYQT SOHCF SRMVM SV3 SWTZT TAE TAOOD TBHMF TDRGL TEORI TH9 TR2 TSG TUS UKHRP VH1 WH7 WOW XOL ZXP ~02 ~8M ~KM AACDK AAHBH AASML AAYZH ABAKF ABBRH ABDBE ABFSG ABRTQ ABZZP ACAOD ACSTC ACUHS ACZOJ AEFQL AEMSY AEUYN AEZWR AFBBN AFDZB AFHIU AGQEE AHWEU AIGIU AIXLP ALIPV ATHPR AYFIA EIHBH FIGPU PHGZM PHGZT PJZUB PPXIY PQGLB ROL SOJ AAYXX ACMFV CITATION IQODW CGR CUY CVF ECM EIF NPM AEIIB PMFND 7QP 7TK 7XB 8FK K9. LK8 MBDVC PKEHL PQEST PQUKI PRINS PUEGO Q9U 7X8 7QL 7QO 7T7 8FD C1K FR3 P64 7S9 L.6 |
| ID | FETCH-LOGICAL-c606t-9481a5e9ca7ca73e73914096d8b50e9056245e111a5b349af783cc6ea22cd42f3 |
| IEDL.DBID | 7X7 |
| ISSN | 0954-3007 1476-5640 |
| IngestDate | Thu Jul 10 19:06:24 EDT 2025 Fri Jul 11 15:07:22 EDT 2025 Fri Jul 11 02:39:07 EDT 2025 Sat Aug 23 14:43:14 EDT 2025 Sat Aug 23 14:59:00 EDT 2025 Tue Jun 17 22:07:50 EDT 2025 Fri Jun 13 00:03:23 EDT 2025 Tue Jun 10 21:05:41 EDT 2025 Wed Feb 19 01:51:35 EST 2025 Mon Jul 21 09:13:30 EDT 2025 Tue Jul 01 03:15:14 EDT 2025 Thu Apr 24 23:02:04 EDT 2025 Mon Jul 21 06:06:58 EDT 2025 Wed Dec 27 19:05:56 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | body weight and measures computed tomography adiponectin abdominal fat cultured milk products probiotics Adipose tissue Body weight Fat mass Visceral obesity Adiponectin Randomization Regulation(control) Adiposity Bacteria Lactobacillaceae Adult Clinical trial Lactobacillus gasseri Cultured milk Human Probiotic Radiodiagnosis Metabolic diseases Corporal biometry Abdomen Medical imagery Computerized axial tomography |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c606t-9481a5e9ca7ca73e73914096d8b50e9056245e111a5b349af783cc6ea22cd42f3 |
| Notes | http://dx.doi.org/10.1038/ejcn.2010.19 ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 ObjectType-Feature-1 |
| PMID | 20216555 |
| PQID | 2642641815 |
| PQPubID | 33883 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_757784475 proquest_miscellaneous_746083236 proquest_miscellaneous_733125567 proquest_journals_356847847 proquest_journals_2642641815 gale_infotracmisc_A228172667 gale_infotracgeneralonefile_A228172667 gale_infotracacademiconefile_A228172667 pubmed_primary_20216555 pascalfrancis_primary_22807363 crossref_citationtrail_10_1038_ejcn_2010_19 crossref_primary_10_1038_ejcn_2010_19 springer_journals_10_1038_ejcn_2010_19 fao_agris_US201301855016 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-06-01 |
| PublicationDateYYYYMMDD | 2010-06-01 |
| PublicationDate_xml | – month: 06 year: 2010 text: 2010-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
| PublicationTitle | European journal of clinical nutrition |
| PublicationTitleAbbrev | Eur J Clin Nutr |
| PublicationTitleAlternate | Eur J Clin Nutr |
| PublicationYear | 2010 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Fujiwara, Seto, Kimura, Hashiba (CR11) 2001; 90 Nakashima, Kamei, Yamane, Nakanishi, Nakashima, Kohno (CR25) 2006; 91 Mater, Bretigny, Firmesse, Flores, Mogenet, Bresson (CR23) 2005; 250 Buijs, Kreier (CR2) 2006; 18 Elwood, Pickering, Hughes, Fehily, Ness (CR7) 2004; 58 Zemel (CR39) 2005; 24 Waki, Yamauchi, Kamon, Ito, Uchida, Kita (CR37) 2003; 278 Turnbaugh, Ley, Mahowald, Magrini, Mardis, Gordon (CR34) 2006; 444 Fujimoto, Abbate, Kahn, Hokanson, Brunzell (CR10) 1994; 2 Tennyson, Friedman (CR32) 2008; 15 Nieves, Cnop, Retzlaff, Walden, Brunzell, Knopp (CR26) 2003; 52 Teegarden (CR31) 2005; 135 Terry, Wood, Haskell, Stefanick, Krauss (CR33) 1989; 68 Takahashi, Fujita, Suzuki, Benno (CR29) 2006; 50 Usman, Hosono (CR35) 1999; 82 Yun, Park, Kang (CR38) 2009; 21 Ley, Turnbaugh, Klein, Gordon (CR22) 2006; 444 Fox, Massaro, Hoffmann, Pou, Maurovich-Horvat, Liu (CR9) 2007; 116 Kawai, Saito, Uemura, Itoh (CR18) 1997; 61 Jayaprakasha, Yoon, Paik (CR16) 2005; 14 Imai, Fukui, Ohta, Tomitsuka, Seto, Fujiwara (CR15) 2002; 21 Abate, Garg (CR1) 1995; 34 Guarner, Perdigon, Corthier, Salminen, Koletzko, Morelli (CR12) 2005; 93 Kawai, Saitoh, Takahashi, Kitazawa, Saito, Nakajima (CR19) 2000; 64 van Harmelen, Skurk, Rohrig, Lee, Halbleib, Aprath-Husmann (CR36) 2003; 27 Kajimoto, Hirata, Aoe, Takahashi, Suzuki, Tanaka (CR17) 2002; 13 Hamad, Sato, Uzu, Yoshida, Higashi, Kawakami (CR13) 2009; 101 Kobayashi, Ouchi, Kihara, Walsh, Kumada, Abe (CR20) 2004; 94 CR8 Elli, Callegari, Ferrari, Bessi, Cattivelli, Soldi (CR6) 2006; 72 Hara, Horikoshi, Yamauchi, Yago, Miyazaki, Ebinuma (CR14) 2006; 29 Cariou, van Harmelen, Duran-Sandoval, van Dijk, Grefhorst, Abdelkarim (CR4) 2006; 281 Kyrou, Chrousos, Tsigos (CR21) 2006; 1083 Sanz, Santacruz, De Palma (CR27) 2008; 2008 Matsuzawa, Funahashi, Kihara, Shimomura (CR24) 2004; 24 DiBaise, Zhang, Crowell, Krajmalnik-Brown, Decker, Rittmann (CR5) 2008; 83 Tchernof, Lamarche, Prud’Homme, Nadeau, Moorjani, Labrie (CR30) 1996; 19 Sato, Uzu, Yoshida, Hamad, Kawakami, Matsuyama (CR28) 2008; 99 Cani, Amar, Iglesias, Poggi, Knauf, Bastelica (CR3) 2007; 56 PC Elwood (BFejcn201019_CR7) 2004; 58 WY Fujimoto (BFejcn201019_CR10) 1994; 2 Y Matsuzawa (BFejcn201019_CR24) 2004; 24 R Nakashima (BFejcn201019_CR25) 2006; 91 RM Buijs (BFejcn201019_CR2) 2006; 18 M Sato (BFejcn201019_CR28) 2008; 99 H Takahashi (BFejcn201019_CR29) 2006; 50 Y Sanz (BFejcn201019_CR27) 2008; 2008 HM Jayaprakasha (BFejcn201019_CR16) 2005; 14 RB Terry (BFejcn201019_CR33) 1989; 68 N Abate (BFejcn201019_CR1) 1995; 34 PD Cani (BFejcn201019_CR3) 2007; 56 EM Hamad (BFejcn201019_CR13) 2009; 101 JK DiBaise (BFejcn201019_CR5) 2008; 83 RE Ley (BFejcn201019_CR22) 2006; 444 K Hara (BFejcn201019_CR14) 2006; 29 D Teegarden (BFejcn201019_CR31) 2005; 135 CA Tennyson (BFejcn201019_CR32) 2008; 15 Y Kawai (BFejcn201019_CR19) 2000; 64 B Cariou (BFejcn201019_CR4) 2006; 281 CS Fox (BFejcn201019_CR9) 2007; 116 DJ Nieves (BFejcn201019_CR26) 2003; 52 H Kobayashi (BFejcn201019_CR20) 2004; 94 DD Mater (BFejcn201019_CR23) 2005; 250 BFejcn201019_CR8 Y Kawai (BFejcn201019_CR18) 1997; 61 Usman (BFejcn201019_CR35) 1999; 82 SI Yun (BFejcn201019_CR38) 2009; 21 MB Zemel (BFejcn201019_CR39) 2005; 24 H Waki (BFejcn201019_CR37) 2003; 278 S Fujiwara (BFejcn201019_CR11) 2001; 90 M Elli (BFejcn201019_CR6) 2006; 72 E Imai (BFejcn201019_CR15) 2002; 21 I Kyrou (BFejcn201019_CR21) 2006; 1083 A Tchernof (BFejcn201019_CR30) 1996; 19 O Kajimoto (BFejcn201019_CR17) 2002; 13 PJ Turnbaugh (BFejcn201019_CR34) 2006; 444 V van Harmelen (BFejcn201019_CR36) 2003; 27 F Guarner (BFejcn201019_CR12) 2005; 93 |
| References_xml | – volume: 83 start-page: 460 year: 2008 end-page: 469 ident: CR5 article-title: Gut microbiota and its possible relationship with obesity publication-title: Mayo Clin Proc doi: 10.4065/83.4.460 – volume: 34 start-page: 53 year: 1995 end-page: 70 ident: CR1 article-title: Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity publication-title: Prog Lipid Res doi: 10.1016/0163-7827(94)00006-8 – volume: 13 start-page: 114 year: 2002 end-page: 124 ident: CR17 article-title: Fermented milk containing Lactobacillus gasseri (SP strain) decreases serum cholesterol concentration in men with boundary and mild hypercholesterolemia publication-title: Jpn J Lactic Acid Bacteria (in Japanese) doi: 10.4109/jslab1997.13.114 – volume: 24 start-page: 537S year: 2005 end-page: 546S ident: CR39 article-title: The role of dairy foods in weight management publication-title: J Am Coll Nutr doi: 10.1080/07315724.2005.10719502 – volume: 99 start-page: 1013 year: 2008 end-page: 1017 ident: CR28 article-title: Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats publication-title: Br J Nutr doi: 10.1017/S0007114507839006 – volume: 21 start-page: 179 year: 2002 end-page: 183 ident: CR15 article-title: Effects of Lactobacillus gasseri SBT2055 on dextran sulfate sodium-induced ulcerative colitis model in rats publication-title: Bioscience Microflora doi: 10.12938/bifidus1996.21.179 – volume: 27 start-page: 889 year: 2003 end-page: 895 ident: CR36 article-title: Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women publication-title: Int J Obes Relat Metab Disord doi: 10.1038/sj.ijo.0802314 – volume: 50 start-page: 867 year: 2006 end-page: 870 ident: CR29 article-title: Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.2006.tb03862.x – volume: 14 start-page: 523 year: 2005 end-page: 528 ident: CR16 article-title: Probiotic functional dairy foods and health claims: an overview publication-title: Food Sci Biotechnol – volume: 24 start-page: 29 year: 2004 end-page: 33 ident: CR24 article-title: Adiponectin and metabolic syndrome publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000099786.99623.EF – volume: 116 start-page: 39 year: 2007 end-page: 48 ident: CR9 article-title: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.675355 – volume: 93 start-page: 783 year: 2005 end-page: 786 ident: CR12 article-title: Should yoghurt cultures be considered probiotic? publication-title: Br J Nutr doi: 10.1079/BJN20051428 – volume: 94 start-page: e27 year: 2004 end-page: e31 ident: CR20 article-title: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin publication-title: Circ Res doi: 10.1161/01.RES.0000119921.86460.37 – volume: 444 start-page: 1027 year: 2006 end-page: 1031 ident: CR34 article-title: An obesity-associated gut microbiome with increased capacity for energy harvest publication-title: Nature doi: 10.1038/nature05414 – volume: 278 start-page: 40352 year: 2003 end-page: 40363 ident: CR37 article-title: Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin publication-title: J Biol Chem doi: 10.1074/jbc.M300365200 – volume: 281 start-page: 11039 year: 2006 end-page: 11049 ident: CR4 article-title: The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice publication-title: J Biol Chem doi: 10.1074/jbc.M510258200 – volume: 90 start-page: 343 year: 2001 end-page: 352 ident: CR11 article-title: Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism publication-title: J Appl Microbiol doi: 10.1046/j.1365-2672.2001.01251.x – ident: CR8 – volume: 56 start-page: 1761 year: 2007 end-page: 1772 ident: CR3 article-title: Metabolic endotoxemia initiates obesity and insulin resistance publication-title: Diabetes doi: 10.2337/db06-1491 – volume: 64 start-page: 2201 year: 2000 end-page: 2208 ident: CR19 article-title: Primary amino acid and DNA sequences of gassericin T, a lactacin F-family bacteriocin produced by Lactobacillus gasseri SBT2055 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.64.2201 – volume: 18 start-page: 715 year: 2006 end-page: 716 ident: CR2 article-title: The metabolic syndrome: a brain disease? publication-title: J Neuroendocrinol doi: 10.1111/j.1365-2826.2006.01456.x – volume: 101 start-page: 716 year: 2009 end-page: 724 ident: CR13 article-title: Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats publication-title: Br J Nutr doi: 10.1017/S0007114508043808 – volume: 2008 start-page: 829101 year: 2008 ident: CR27 article-title: Insights into the roles of gut microbes in obesity publication-title: Interdiscip Perspect Infect Dis doi: 10.1155/2008/829101 – volume: 21 start-page: 21 year: 2009 ident: CR38 article-title: Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes publication-title: J Appl Microbiol – volume: 61 start-page: 179 year: 1997 end-page: 182 ident: CR18 article-title: Rapid detection method for bacteriocin and distribution of bacteriocin-producing strains in Lactobacillus acidophilus group lactic acid bacteria isolated from human feces publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.61.179 – volume: 15 start-page: 422 year: 2008 end-page: 427 ident: CR32 article-title: Microecology, obesity, and probiotics publication-title: Curr Opin Endocrinol Diabetes Obes doi: 10.1097/MED.0b013e328308dbfb – volume: 250 start-page: 185 year: 2005 end-page: 187 ident: CR23 article-title: Streptococcus thermophilus and Lactobacillus delbrueckii subsp. Bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt publication-title: FEMS Microbiol Lett doi: 10.1016/j.femsle.2005.07.006 – volume: 19 start-page: 629 year: 1996 end-page: 637 ident: CR30 article-title: The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men publication-title: Diabetes Care doi: 10.2337/diacare.19.6.629 – volume: 1083 start-page: 77 year: 2006 end-page: 110 ident: CR21 article-title: Stress, visceral obesity, and metabolic complications publication-title: Ann NY Acad Sci doi: 10.1196/annals.1367.008 – volume: 91 start-page: 3873 year: 2006 end-page: 3877 ident: CR25 article-title: Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1158 – volume: 2 start-page: 364 year: 1994 end-page: 371 ident: CR10 article-title: The visceral adiposity syndrome in Japanese-American men publication-title: Obes Res doi: 10.1002/j.1550-8528.1994.tb00076.x – volume: 68 start-page: 191 year: 1989 end-page: 199 ident: CR33 article-title: Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-68-1-191 – volume: 82 start-page: 243 year: 1999 end-page: 248 ident: CR35 article-title: Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains publication-title: J Dairy Sci doi: 10.3168/jds.S0022-0302(99)75229-X – volume: 58 start-page: 718 year: 2004 end-page: 724 ident: CR7 article-title: Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1601869 – volume: 72 start-page: 5113 year: 2006 end-page: 5117 ident: CR6 article-title: Survival of yogurt bacteria in the human gut publication-title: Appl Environ Microbiol doi: 10.1128/AEM.02950-05 – volume: 135 start-page: 2749 year: 2005 end-page: 2752 ident: CR31 article-title: The influence of dairy product consumption on body composition publication-title: J Nutr doi: 10.1093/jn/135.12.2749 – volume: 52 start-page: 172 year: 2003 end-page: 179 ident: CR26 article-title: The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat publication-title: Diabetes doi: 10.2337/diabetes.52.1.172 – volume: 29 start-page: 1357 year: 2006 end-page: 1362 ident: CR14 article-title: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome publication-title: Diabetes Care doi: 10.2337/dc05-1801 – volume: 444 start-page: 1022 year: 2006 end-page: 1023 ident: CR22 article-title: Microbial ecology: human gut microbes associated with obesity publication-title: Nature doi: 10.1038/4441022a – volume: 82 start-page: 243 year: 1999 ident: BFejcn201019_CR35 publication-title: J Dairy Sci doi: 10.3168/jds.S0022-0302(99)75229-X – volume: 29 start-page: 1357 year: 2006 ident: BFejcn201019_CR14 publication-title: Diabetes Care doi: 10.2337/dc05-1801 – volume: 116 start-page: 39 year: 2007 ident: BFejcn201019_CR9 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.675355 – volume: 281 start-page: 11039 year: 2006 ident: BFejcn201019_CR4 publication-title: J Biol Chem doi: 10.1074/jbc.M510258200 – volume: 19 start-page: 629 year: 1996 ident: BFejcn201019_CR30 publication-title: Diabetes Care doi: 10.2337/diacare.19.6.629 – volume: 64 start-page: 2201 year: 2000 ident: BFejcn201019_CR19 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.64.2201 – volume: 24 start-page: 29 year: 2004 ident: BFejcn201019_CR24 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000099786.99623.EF – volume: 15 start-page: 422 year: 2008 ident: BFejcn201019_CR32 publication-title: Curr Opin Endocrinol Diabetes Obes doi: 10.1097/MED.0b013e328308dbfb – volume: 21 start-page: 21 year: 2009 ident: BFejcn201019_CR38 publication-title: J Appl Microbiol – volume: 94 start-page: e27 year: 2004 ident: BFejcn201019_CR20 publication-title: Circ Res doi: 10.1161/01.RES.0000119921.86460.37 – volume: 444 start-page: 1022 year: 2006 ident: BFejcn201019_CR22 publication-title: Nature doi: 10.1038/4441022a – volume: 91 start-page: 3873 year: 2006 ident: BFejcn201019_CR25 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1158 – volume: 14 start-page: 523 year: 2005 ident: BFejcn201019_CR16 publication-title: Food Sci Biotechnol – volume: 2008 start-page: 829101 year: 2008 ident: BFejcn201019_CR27 publication-title: Interdiscip Perspect Infect Dis doi: 10.1155/2008/829101 – volume: 2 start-page: 364 year: 1994 ident: BFejcn201019_CR10 publication-title: Obes Res doi: 10.1002/j.1550-8528.1994.tb00076.x – volume: 68 start-page: 191 year: 1989 ident: BFejcn201019_CR33 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-68-1-191 – volume: 21 start-page: 179 year: 2002 ident: BFejcn201019_CR15 publication-title: Bioscience Microflora doi: 10.12938/bifidus1996.21.179 – volume: 250 start-page: 185 year: 2005 ident: BFejcn201019_CR23 publication-title: FEMS Microbiol Lett doi: 10.1016/j.femsle.2005.07.006 – volume: 135 start-page: 2749 year: 2005 ident: BFejcn201019_CR31 publication-title: J Nutr doi: 10.1093/jn/135.12.2749 – volume: 93 start-page: 783 year: 2005 ident: BFejcn201019_CR12 publication-title: Br J Nutr doi: 10.1079/BJN20051428 – volume: 52 start-page: 172 year: 2003 ident: BFejcn201019_CR26 publication-title: Diabetes doi: 10.2337/diabetes.52.1.172 – volume: 278 start-page: 40352 year: 2003 ident: BFejcn201019_CR37 publication-title: J Biol Chem doi: 10.1074/jbc.M300365200 – volume: 13 start-page: 114 year: 2002 ident: BFejcn201019_CR17 publication-title: Jpn J Lactic Acid Bacteria (in Japanese) doi: 10.4109/jslab1997.13.114 – volume: 27 start-page: 889 year: 2003 ident: BFejcn201019_CR36 publication-title: Int J Obes Relat Metab Disord doi: 10.1038/sj.ijo.0802314 – volume: 18 start-page: 715 year: 2006 ident: BFejcn201019_CR2 publication-title: J Neuroendocrinol doi: 10.1111/j.1365-2826.2006.01456.x – volume: 56 start-page: 1761 year: 2007 ident: BFejcn201019_CR3 publication-title: Diabetes doi: 10.2337/db06-1491 – volume: 24 start-page: 537S year: 2005 ident: BFejcn201019_CR39 publication-title: J Am Coll Nutr doi: 10.1080/07315724.2005.10719502 – volume: 72 start-page: 5113 year: 2006 ident: BFejcn201019_CR6 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.02950-05 – volume: 61 start-page: 179 year: 1997 ident: BFejcn201019_CR18 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.61.179 – volume: 34 start-page: 53 year: 1995 ident: BFejcn201019_CR1 publication-title: Prog Lipid Res doi: 10.1016/0163-7827(94)00006-8 – volume: 99 start-page: 1013 year: 2008 ident: BFejcn201019_CR28 publication-title: Br J Nutr doi: 10.1017/S0007114507839006 – volume: 50 start-page: 867 year: 2006 ident: BFejcn201019_CR29 publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.2006.tb03862.x – volume: 58 start-page: 718 year: 2004 ident: BFejcn201019_CR7 publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1601869 – volume: 83 start-page: 460 year: 2008 ident: BFejcn201019_CR5 publication-title: Mayo Clin Proc doi: 10.4065/83.4.460 – volume: 1083 start-page: 77 year: 2006 ident: BFejcn201019_CR21 publication-title: Ann NY Acad Sci doi: 10.1196/annals.1367.008 – volume: 101 start-page: 716 year: 2009 ident: BFejcn201019_CR13 publication-title: Br J Nutr doi: 10.1017/S0007114508043808 – volume: 444 start-page: 1027 year: 2006 ident: BFejcn201019_CR34 publication-title: Nature doi: 10.1038/nature05414 – volume: 90 start-page: 343 year: 2001 ident: BFejcn201019_CR11 publication-title: J Appl Microbiol doi: 10.1046/j.1365-2672.2001.01251.x – ident: BFejcn201019_CR8 |
| SSID | ssj0014772 |
| Score | 2.5200553 |
| Snippet | Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We... Background/Objectives: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We... In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the... Subjects/Methods: We conducted a multicenter, double-blind, randomized, placebo-controlled intervention trial. Subjects (n = 87) with higher body mass index... Background/Objectives:In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We... BACKGROUND/OBJECTIVES: In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We... |
| SourceID | proquest gale pubmed pascalfrancis crossref springer fao |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 636 |
| SubjectTerms | 631/45/776/1178 692/699/1503/1702/393 692/700/565/2072 Abdomen abdominal fat Abdominal Fat - metabolism Active control Adiponectin Adiponectin - blood Adipose tissue Adipose tissues Adult Adults Biological and medical sciences blood Blood cholesterol Body fat Body Mass Index Body size Body Weight Clinical Nutrition Clinical trials Composition Computed tomography Confidence intervals Control Double-Blind Method drug therapy Epidemiology Feeding. Feeding behavior Female fermented milk Fermented milk products functional foods Fundamental and applied biological sciences. Psychology Health aspects Hip Humans Internal Medicine Intra-Abdominal Fat Intra-Abdominal Fat - metabolism Lactobacillus Lactobacillus gasseri Male Medical sciences Medicine Medicine & Public Health Metabolic Diseases Metabolic disorders metabolism Middle Aged Molecular weight nutritional intervention Obesity Obesity - drug therapy Obesity - metabolism Obesity, Abdominal Obesity, Abdominal - drug therapy Obesity, Abdominal - metabolism original-article Prevention Probiotics Probiotics - therapeutic use Public Health randomized clinical trials Subcutaneous Fat, Abdominal Subcutaneous Fat, Abdominal - metabolism therapeutic use Vertebrates: anatomy and physiology, studies on body, several organs or systems Waist Circumference Weight control |
| Title | Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial |
| URI | https://link.springer.com/article/10.1038/ejcn.2010.19 https://www.ncbi.nlm.nih.gov/pubmed/20216555 https://www.proquest.com/docview/2642641815 https://www.proquest.com/docview/356847847 https://www.proquest.com/docview/733125567 https://www.proquest.com/docview/746083236 https://www.proquest.com/docview/757784475 |
| Volume | 64 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLXY9oKEEGzAwkblByggFC2NP5I8oW5smhBUaFulvUX-SlVUkkLah_Ir-Mnc66Qd1Uolq2rrW9mp7Zvj65tzCHktpRGF0VHIWapCnlodKpuZkCepUj3DrRX4vPPXgbwc8s-34rbNzanbtMqlT_SO2lYGY-QnTEhwpFA-Tn-GKBqFh6utgsYO2UPmMszoSm5X-60eT7x2E4AIDP5HSZv3HrH0xH03ZZPXhRQ7_9yRdgpVrbzzo6mq4Z8qGomLTRj03vmpvy1dPCGPWzxJ-80EeEoeuHKfHPRL2Ev_WNAu9RmePnS-T4JPYzeD71ou0AkdLKn4D8ifq0aUHj7QqqBK28rLfVFlxz6xa0H1gk49axMyO9N3X1CpRysznkzmNR0pPNcf0-vTmzgS4j0dl9Rze9QUQ7200q521AfcUQ649vUULhnb-e0sbXPmJ_DWK4k8I8OL85uzy7BVawgNbIJmIdK-KOEyoxIozCUsQzItaVMtIpch0OLCgWtVQjOeqSJJmTHSqTg2lscFe052y6p0h4QyFUlthDZQwQGiZdZy69IU0KvOVKQD8mE5YrlpqcxRUWOS-yN1luY4vjmOb97LAvJmZT1tKDz-Y3cIg5-rEXjXfHgd45luD_neejIgb3FG5LjooSGj2mcXoLtIn5X34zgFJChlEpDumuWoIQ_fZHi8Zgir2qxVd9Ym36rnnr6ISQa_X87GvHU7dQ7oFgqANhGQo_vVqzUUELqqxYYx0a501bzOUcITWem2mXAJuD1mcouJSKAZnkA3XjQL5a7_ACqlEFDTXa6cuw5uGpaXW6_kiDxs8jkwLnZMdme_5u4VwMSZ7nhnAK_pWa9D9k7PB9-u_gKGymdC |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELf25wEkhGADFjaGH9gAoWhp_CfJA0Id27SxrULbKu0t2I5bFZWkkE6ofAq-CN-ROyfpqFb2NikPVe9aOzr7_LPv_DtCXklpRM_owOcsVj6PM-2rLDE-j2KlWoZnmcD7zqcdedjlny7F5QL509yFwbTKxic6R50VBs_Id5iQ4Ejh-TD67mPRKAyuNhU0qlFxbCc_YcdWvj_aA_NuheHB_sXHQ78uKuAbwOpjH9lJlLCJURE8zEYsQc4nmcVaBDZBPMCFBQ-ghGY8Ub0oZsZIq8LQZDzsMfjfRbLMGexklsjy7n7n89k0bMEjVy0KYAuGG4KozrQPWLxjv5q8yiRDUp9_1sDFniqm68GDkSrBNr2qqMY81HsjYusWwoNH5GGNYGm7GnKPyYLNV8hqO4fd-7cJ3aYup9Qd1q8Qb29gx_BdzT46pJ2G_H-V_D6z_bp2GC16VOmscAXGqMoGLpVsQvWEjhxPFHJJ0zcnWBtIKzMYDq9K2leYSTCg57sXYSDEWzrIqWMTKSkeLtNC29JSd8SPBYhLJ6fwytjOL5vROkt_CB9d7ZInpHsnpnxKlvIit2uEMhVIbYQ2IOAACpMs45mNY8DLOlGB9si7xmKpqcnTsYbHMHVBfBanaN8U7Zu2Eo9sTbVHFWnIf_TWwPip6oM_T7vnIUaRW8gw15IeeY0jIkU3Aw0ZVd-WgO4iYVfaDsMYsKeUkUe2ZzT7FV35PMWNGUXwI2ZGvDkz-KY9d4RJTDL4fTMa09rRlSngaXgAJgqPrN8UT2etR-hUig1jal9ui6syxaKhyIN3mwqXsFMImbxFRUTQDI-gG8-qiXLdf4CxUgiQbDcz57qD88zy_NY3eUnuHV6cnqQnR53jdXK_yibBU7kNsjT-cWVfAEgd683aNVDy5a690V8MEaIm |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1dTxQxFG0AE2NijILKCGIfBDVkwuz0Y2YejEGRgCAxAglvte10NmvWmdVZYtZf4d_x33lvZ2ZxA_JGMg-b7d1tJ7e9PW1vzyHkuZRWFNZEIWepDnmam1DnmQ15kmrdszzPBd53_ngk9075hzNxNkf-dHdhMK2yi4k-UOeVxT3yLSYkBFJ4too2K-LTzu6b0fcQBaTwoLVT02h6yIGb_ITVW_16fwdcvR7Hu-9P3u2FrcBAaAG3j0NkKtHCZVYn8DCXsAz5n2SeGhG5DLEBFw6igRaG8UwXScqslU7Hsc15XDD433lyK2Gih0MsOZuu9Xo88bpRAGDw4CFK2pz7iKVb7qstm5wypPf5ZzacL3Q1nRnujnQNXioaeY2r8O-ls1s_Je7eJ_daLEu3m873gMy5cpEsbZewjv82oRvUZ5f6bftFEuwM3Bi-a3lIh_SokwFYIr8_u36rIkargmqTV15qjOp84JPKJtRM6MgzRiGrNH15iCpBRtvBcHhe077GnIIBPX57EkdCvKKDknpekZriNjOtjKsd9Zv9KEVc-3IKr4z1_HI5bfP1h_DRq5g8JKc34shHZKGsSrdMKNORNFYYCwUc4GGW5zx3aQrI2WQ6MgHZ7DymbEujjmoeQ-WP81mq0L8K_at6WUDWp9ajhj7kP3bL4Hyl-xDZ1elxjOfJPeSa68mAvMAeoTDgQEVWt_cmoLlI3aW24zgFFCplEpCNGct-Q1x-leHqjCFEFDtTvDbT-aYt99RJTDL4fdcbVRvyagXIGh4AjCIgK5eLp-M3IHRaihVjkl_pqvNaoXwoMuJdZ8IlrBliJq8xEQlUwxNoxuNmoFy0HwCtFAJKNrqRc9HAq9zy5No3eUZuQwxSh_tHByvkTpNWgttzq2Rh_OPcPQW0OjZrPi5Q8uWmA9Ff28yk9g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Regulation+of+abdominal+adiposity+by+probiotics+%28Lactobacillus+gasseri+SBT2055%29+in+adults+with+obese+tendencies+in+a+randomized+controlled+trial&rft.jtitle=European+journal+of+clinical+nutrition&rft.au=Kadooka%2C+Y&rft.au=Sato%2C+M&rft.au=Imaizumi%2C+K&rft.au=Ogawa%2C+A&rft.date=2010-06-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0954-3007&rft.eissn=1476-5640&rft.volume=64&rft.issue=6&rft.spage=636&rft.epage=643&rft_id=info:doi/10.1038%2Fejcn.2010.19&rft.externalDocID=10_1038_ejcn_2010_19 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-3007&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-3007&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-3007&client=summon |